Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica
Abstract Background It has been hypothesized that 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography (PET) computed tomography (CT) can distinguish polymyalgia rheumatica (PMR) from non-PMR patients based on the [18F]FDG-uptake patterns. Nevertheless, a comprehensive assessment...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-04-01
|
| Series: | EJNMMI Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13550-025-01233-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849314712105254912 |
|---|---|
| author | Andreas Wiggers Nielsen Gijs D. van Praagh Kornelis S. M. van der Geest Ib Tønder Hansen Berit Dalsgaard Nielsen Søren Geill Kjær Jesper Blegvad-Nissen Kate Rewers Christian Møller Sørensen Elisabeth Brouwer Ellen-Margrethe Hauge Lars Christian Gormsen Riemer H. J. A. Slart Kresten Krarup Keller |
| author_facet | Andreas Wiggers Nielsen Gijs D. van Praagh Kornelis S. M. van der Geest Ib Tønder Hansen Berit Dalsgaard Nielsen Søren Geill Kjær Jesper Blegvad-Nissen Kate Rewers Christian Møller Sørensen Elisabeth Brouwer Ellen-Margrethe Hauge Lars Christian Gormsen Riemer H. J. A. Slart Kresten Krarup Keller |
| author_sort | Andreas Wiggers Nielsen |
| collection | DOAJ |
| description | Abstract Background It has been hypothesized that 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography (PET) computed tomography (CT) can distinguish polymyalgia rheumatica (PMR) from non-PMR patients based on the [18F]FDG-uptake patterns. Nevertheless, a comprehensive assessment of whole-body [18F]FDG-patterns across all uptaking musculoskeletal sites, as well as site-specific [18F]FDG-uptake patterns, has not been conducted. Therefore, this study aimed to investigate both the overall whole-body [18F]FDG-uptake patterns and the specific uptake patterns at individual sites in patients suspected of having PMR. Methods Two distinct cohorts of patients with suspected PMR from Denmark and the Netherlands were prospectively included, encompassing 66/27 and 36/21 PMR/non-PMR patients, respectively. The cohorts consisted of treatment-naïve patients, who underwent pre-treatment [18F]FDG-PET/CT scans. The [18F]FDG-uptake was then assessed across 34 different anatomical sites. Furthermore, the site-specific [18F]FDG-uptake pattern within each anatomical site was categorized according to its shape. Results Patients with PMR were more likely than non-PMR patients to have bilateral [18F]FDG-uptake equal to or above liver compared at the ischial tuberosities (91%/41%), shoulder joints (86%/45%), hip joints (83%/52%), and along the lumbar spinal processes (70%/30%). However, a subgroup analysis comparing non-PMR patients with other inflammatory conditions to patients with PMR revealed that several non-PMR patients exhibited a similar whole-body [18F]FDG-uptake pattern. Furthermore, site-specific [18F]FDG-uptake patterns were similar in patients with PMR and non-PMR. Conclusion Assessing whole-body or site-specific [18F]FDG-uptake patterns does not improve the diagnostic accuracy in distinguishing PMR from other inflammatory diseases. Consequently, [18F]FDG-PET/CT should mainly be used to rule out a clinical diagnosis of PMR. Trial registration: ClinicalTrials.gov (NCT04519580). Registered 17th of August 2020. |
| format | Article |
| id | doaj-art-6920a359534a40eb86b3a6042bb36e4f |
| institution | Kabale University |
| issn | 2191-219X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | EJNMMI Research |
| spelling | doaj-art-6920a359534a40eb86b3a6042bb36e4f2025-08-20T03:52:23ZengSpringerOpenEJNMMI Research2191-219X2025-04-0115111510.1186/s13550-025-01233-7Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumaticaAndreas Wiggers Nielsen0Gijs D. van Praagh1Kornelis S. M. van der Geest2Ib Tønder Hansen3Berit Dalsgaard Nielsen4Søren Geill Kjær5Jesper Blegvad-Nissen6Kate Rewers7Christian Møller Sørensen8Elisabeth Brouwer9Ellen-Margrethe Hauge10Lars Christian Gormsen11Riemer H. J. A. Slart12Kresten Krarup Keller13Department of Rheumatology, Aarhus University Hospital, Led- Og BindevævssygdommeDepartment of Nuclear Medicine and Molecular Imaging, University Medical Centre GroningenDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center GroningenDepartment of Rheumatology, Aarhus University Hospital, Led- Og BindevævssygdommeDepartment of Rheumatology, Aarhus University Hospital, Led- Og BindevævssygdommeDiagnostic Centre, Silkeborg Regional HospitalDiagnostic Centre, Silkeborg Regional HospitalDepartment of Nuclear Medicine and PET, Odense University HospitalDepartment of Internal Medicine, Horsens Regional HospitalDepartment of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center GroningenDepartment of Rheumatology, Aarhus University Hospital, Led- Og BindevævssygdommeDepartment of Clinical Medicine, Aarhus UniversityDepartment of Nuclear Medicine and Molecular Imaging, University Medical Centre GroningenDepartment of Rheumatology, Aarhus University Hospital, Led- Og BindevævssygdommeAbstract Background It has been hypothesized that 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography (PET) computed tomography (CT) can distinguish polymyalgia rheumatica (PMR) from non-PMR patients based on the [18F]FDG-uptake patterns. Nevertheless, a comprehensive assessment of whole-body [18F]FDG-patterns across all uptaking musculoskeletal sites, as well as site-specific [18F]FDG-uptake patterns, has not been conducted. Therefore, this study aimed to investigate both the overall whole-body [18F]FDG-uptake patterns and the specific uptake patterns at individual sites in patients suspected of having PMR. Methods Two distinct cohorts of patients with suspected PMR from Denmark and the Netherlands were prospectively included, encompassing 66/27 and 36/21 PMR/non-PMR patients, respectively. The cohorts consisted of treatment-naïve patients, who underwent pre-treatment [18F]FDG-PET/CT scans. The [18F]FDG-uptake was then assessed across 34 different anatomical sites. Furthermore, the site-specific [18F]FDG-uptake pattern within each anatomical site was categorized according to its shape. Results Patients with PMR were more likely than non-PMR patients to have bilateral [18F]FDG-uptake equal to or above liver compared at the ischial tuberosities (91%/41%), shoulder joints (86%/45%), hip joints (83%/52%), and along the lumbar spinal processes (70%/30%). However, a subgroup analysis comparing non-PMR patients with other inflammatory conditions to patients with PMR revealed that several non-PMR patients exhibited a similar whole-body [18F]FDG-uptake pattern. Furthermore, site-specific [18F]FDG-uptake patterns were similar in patients with PMR and non-PMR. Conclusion Assessing whole-body or site-specific [18F]FDG-uptake patterns does not improve the diagnostic accuracy in distinguishing PMR from other inflammatory diseases. Consequently, [18F]FDG-PET/CT should mainly be used to rule out a clinical diagnosis of PMR. Trial registration: ClinicalTrials.gov (NCT04519580). Registered 17th of August 2020.https://doi.org/10.1186/s13550-025-01233-7Polymyalgia rheumaticaDiagnostic imagingFDG-PET/CTPattern recognition |
| spellingShingle | Andreas Wiggers Nielsen Gijs D. van Praagh Kornelis S. M. van der Geest Ib Tønder Hansen Berit Dalsgaard Nielsen Søren Geill Kjær Jesper Blegvad-Nissen Kate Rewers Christian Møller Sørensen Elisabeth Brouwer Ellen-Margrethe Hauge Lars Christian Gormsen Riemer H. J. A. Slart Kresten Krarup Keller Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica EJNMMI Research Polymyalgia rheumatica Diagnostic imaging FDG-PET/CT Pattern recognition |
| title | Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica |
| title_full | Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica |
| title_fullStr | Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica |
| title_full_unstemmed | Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica |
| title_short | Whole-body and site specific [18F]FDG uptake patterns on PET/CT have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases: two cohorts of treatment-naïve suspected polymyalgia rheumatica |
| title_sort | whole body and site specific 18f fdg uptake patterns on pet ct have limited value in differentiating between polymyalgia rheumatica and other inflammatory diseases two cohorts of treatment naive suspected polymyalgia rheumatica |
| topic | Polymyalgia rheumatica Diagnostic imaging FDG-PET/CT Pattern recognition |
| url | https://doi.org/10.1186/s13550-025-01233-7 |
| work_keys_str_mv | AT andreaswiggersnielsen wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT gijsdvanpraagh wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT kornelissmvandergeest wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT ibtønderhansen wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT beritdalsgaardnielsen wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT sørengeillkjær wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT jesperblegvadnissen wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT katerewers wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT christianmøllersørensen wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT elisabethbrouwer wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT ellenmargrethehauge wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT larschristiangormsen wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT riemerhjaslart wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica AT krestenkrarupkeller wholebodyandsitespecific18ffdguptakepatternsonpetcthavelimitedvalueindifferentiatingbetweenpolymyalgiarheumaticaandotherinflammatorydiseasestwocohortsoftreatmentnaivesuspectedpolymyalgiarheumatica |